Frank Thomas

Frank E.
Thomas is Chairman at Spero Therapeutics, Inc. since 2025.
Holds director positions at Orchard Therapeutics North America and Larimar Therapeutics, Inc. since 2014.
Serves as President & Chief Operating Officer at Orchard Therapeutics (Europe) Ltd. since 2020 and at Orchard Therapeutics Plc since 2018.
Former roles include President, Chief Executive Officer & Director at Critical Therapeutics, Inc. from 2006 to 2008; Controller & Finance Director at Mechanical Dynamics, Inc. from 1997 to 2000; Independent Director at Zafgen, Inc.; Director at Massachusetts Biotechnology Council from 2007 to 2015; Chief Financial Officer & VP-Investor Relations at Esperion Therapeutics, Inc. from 2000 to 2004; Chief Operating Officer & Senior Vice President at Molecular Biometrics, Inc. from 2010 to 2011; Principal at Arthur Andersen LLP from 1992 to 2000; and President & Chief Operating Officer at AMAG Pharmaceuticals, Inc. from 2016 to 2017.
Education includes undergraduate studies at the University of Michigan.